13D Filing: Farallon Capital and Nexvet Biopharma PLC (NVET)

Page 52 of 68

Page 52 of 68 – SEC Filing

SCHEDULE
Convertible Securities details
Bushranger Funding, LLC holds warrants, issued by the Company on November 18, 2014, to purchase 229,172 ordinary shares of the Company at an exercise price of $8.625 (subject to adjustment pursuant to the terms of such warrants).  Such warrants expire by their terms on April 30, 2019.
IN WITNESS whereof this Deed has been duly executed and delivered as a deed poll on the date shown at the beginning of this document.
EXECUTED and DELIVERED as a DEED
by, for, and on behalf of

BUSHRANGER FUNDING, LLC

By: Farallon Capital Management, L.L.C., its Manager
By:    /s/ Rajiv A. Patel
          Name: Rajiv A. Patel
          Title:   Managing Member

Follow Nexvet Biopharma Plc (NASDAQ:NVET)

Page 52 of 68